| A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 (NCT03346187) | Chong Kun Dang Pharmaceutical | 2017-05-19 |
| Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer (NCT02898207) | National Cancer Institute (NCI) | 2017-05-19 |
| Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial. (NCT03172117) | Medipost Co Ltd. | 2017-05-19 |
| A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001 (NCT03126318) | University of Colorado, Denver | 2017-05-19 |
| A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet (NCT03156127) | Boryung Pharmaceutical Co., Ltd | 2017-05-19 |
| Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults (NCT03135028) | Gilead Sciences | 2017-05-19 |
| Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC (NCT02987998) | Nathan Pennell, MD, PhD | 2017-05-19 |
| Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers (NCT03118817) | Hanmi Pharmaceutical Company Limited | 2017-05-19 |
| Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression (NCT03125200) | ADC Therapeutics S.A. | 2017-05-18 |
| BI 443651 Methacholine Challenge (NCT03135899) | Boehringer Ingelheim | 2017-05-18 |
| A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects (NCT06094790) | Corcept Therapeutics | 2017-05-18 |
| Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis (NCT02866903) | Hospices Civils de Lyon | 2017-05-18 |
| Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms (NCT03072043) | H. Lee Moffitt Cancer Center and Research Institute | 2017-05-18 |
| Neural Stem Cell Transplantation in Multiple Sclerosis Patients (NCT03269071) | IRCCS San Raffaele | 2017-05-17 |
| A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease (NCT03112096) | Asan Foundation | 2017-05-17 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease (NCT03033498) | AbbVie | 2017-05-17 |
| A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM) (NCT02803918) | Sanofi | 2017-05-17 |
| A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers (NCT03156738) | Tanabe Pharma Corporation | 2017-05-17 |
| Study of GSK2586881 on Acute Hypoxia and Exercise (NCT03000686) | GlaxoSmithKline | 2017-05-17 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy Participants (NCT03139500) | Janssen Research & Development, LLC | 2017-05-17 |
| Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment (NCT02389231) | University Hospital, Bordeaux | 2017-05-17 |
| A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain (NCT03089918) | Janssen Research & Development, LLC | 2017-05-17 |
| A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers (NCT03154086) | GlaxoSmithKline | 2017-05-17 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789 (NCT03163550) | Achaogen, Inc. | 2017-05-17 |
| Preoperative Radiotherapy and E7046 in Rectum Cancer (NCT03152370) | Adlai Nortye Biopharma Co., Ltd. | 2017-05-17 |
| Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02627443) | National Cancer Institute (NCI) | 2017-05-16 |
| Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults (NCT03430349) | Pierre Van Damme | 2017-05-16 |
| Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects (NCT03150108) | Shire | 2017-05-16 |
| Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma (NCT03159117) | Memorial Sloan Kettering Cancer Center | 2017-05-16 |
| A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting (NCT03083821) | Bristol-Myers Squibb | 2017-05-16 |
| Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. (NCT03225417) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2017-05-16 |
| Treatment of TK2 Deficiency With Thymidine and Deoxycytidine (NCT03639701) | Columbia University | 2017-05-16 |
| Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV) (NCT03146741) | University of Pennsylvania | 2017-05-16 |
| Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects (NCT03123094) | Boehringer Ingelheim | 2017-05-16 |
| Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma (NCT03145181) | Janssen Research & Development, LLC | 2017-05-16 |
| Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects (NCT03198624) | Nxera Pharma UK Limited | 2017-05-16 |
| Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002) (NCT03094832) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2017-05-16 |
| Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? (NCT03102645) | Jonatan Kornholt | 2017-05-16 |
| Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers (NCT03146416) | Regeneron Pharmaceuticals | 2017-05-16 |
| Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas (NCT03042819) | University Health Network, Toronto | 2017-05-16 |
| Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Adult Healthy Subjects (NCT03145038) | Bayer | 2017-05-16 |
| A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease (NCT03136991) | AstraZeneca | 2017-05-15 |
| A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability (NCT03329014) | Paion UK Ltd. | 2017-05-15 |
| Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers (NCT02992964) | The Hospital for Sick Children | 2017-05-15 |
| MAGE-A4ᶜ¹º³²T for Multi-Tumor (NCT03132922) | USWM CT, LLC | 2017-05-15 |
| Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease (NCT03142529) | Pang Peng | 2017-05-15 |
| AMG 529 First in Human Study (NCT03170193) | Amgen | 2017-05-15 |
| Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia (NCT03397680) | Thammasat University | 2017-05-15 |
| Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects (NCT03327558) | Bausch Health Americas, Inc. | 2017-05-15 |
| Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours (NCT03101839) | AstraZeneca | 2017-05-15 |
| Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese Participants (NCT03096795) | MedImmune LLC | 2017-05-15 |
| Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness (NCT03069482) | Duke University | 2017-05-15 |
| A Study With GLPG1972 in Osteoarthritis Subjects (NCT03311009) | Lakefront Biotherapeutics NV | 2017-05-15 |
| Nasal Human Abuse Potential of PTI-821 (NCT03475862) | Pain Therapeutics | 2017-05-15 |
| Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects (NCT03189615) | H. Lundbeck A/S | 2017-05-14 |
| Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin (NCT03131973) | Bristol-Myers Squibb | 2017-05-13 |
| Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers (NCT03163121) | Sanaria Inc. | 2017-05-12 |
| A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered (NCT03126695) | AstraZeneca | 2017-05-12 |
| Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers (NCT03035760) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-05-12 |
| A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants (NCT03155893) | Janssen Research & Development, LLC | 2017-05-12 |
| A Study of SY-1365 in Adult Patients With Advanced Solid Tumors (NCT03134638) | Syros Pharmaceuticals | 2017-05-12 |
| Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women (NCT03223987) | Bio-Strath AG | 2017-05-11 |
| Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers (NCT03148925) | Selecta Biosciences, Inc. | 2017-05-11 |
| Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation (NCT03047629) | Enterin Inc. | 2017-05-11 |
| Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease (NCT03065192) | Neurocrine Biosciences | 2017-05-11 |
| A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants (NCT03142165) | Bristol-Myers Squibb | 2017-05-11 |
| Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) Chemotherapy (NCT03135951) | Spectrum Pharmaceuticals, Inc | 2017-05-11 |
| A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors (NCT03057366) | Millennium Pharmaceuticals, Inc. | 2017-05-11 |
| Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes (NCT03113773) | Cambridge University Hospitals NHS Foundation Trust | 2017-05-11 |
| Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II (NCT03041324) | Sangamo Therapeutics | 2017-05-11 |
| A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics (NCT02996838) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2017-05-11 |
| Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas (NCT03119467) | Rhizen Pharmaceuticals SA | 2017-05-11 |
| First in Human Study for PF-06667272 (NCT03126149) | Pfizer | 2017-05-11 |
| Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. (NCT03187496) | Enanta Pharmaceuticals, Inc | 2017-05-11 |
| Food Effect Study of ModraDoc006 in Combination With Ritonavir (NCT03147378) | Modra Pharmaceuticals | 2017-05-10 |
| Study of Danirixin in Japanese Healthy Elderly Male Subjects (NCT03136380) | GlaxoSmithKline | 2017-05-10 |
| Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State (NCT03086356) | Boehringer Ingelheim | 2017-05-10 |
| Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512 (NCT03146065) | Pfizer | 2017-05-10 |
| Marijuana in Combination With Opioids in Palliative and Hospice Patients (NCT03233633) | The Connecticut Hospice Inc. | 2017-05-10 |
| CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma (NCT03150316) | Chong Kun Dang Pharmaceutical | 2017-05-10 |
| Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers (NCT03115996) | Regeneron Pharmaceuticals | 2017-05-10 |
| A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898 (NCT03140072) | AstraZeneca | 2017-05-10 |
| Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers (NCT03191136) | Yuhan Corporation | 2017-05-10 |
| Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma (NCT02257242) | Brown University | 2017-05-10 |
| Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer (NCT02898116) | Ludwig Institute for Cancer Research | 2017-05-10 |
| Immunotherapy Study of Evofosfamide in Combination With Ipilimumab (NCT03098160) | Threshold Pharmaceuticals | 2017-05-10 |
| Extended Use of ModraDoc006/r (NCT03150368) | Modra Pharmaceuticals | 2017-05-10 |
| Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma (NCT03131167) | Shire | 2017-05-10 |
| Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer (NCT03122717) | Dana-Farber Cancer Institute | 2017-05-09 |
| Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers (NCT03060447) | Gilead Sciences | 2017-05-09 |
| A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients (NCT03165955) | Health Hope Pharma | 2017-05-09 |
| Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes (NCT02960659) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-05-09 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers (NCT03165864) | Ionis Pharmaceuticals, Inc. | 2017-05-09 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis (NCT03145948) | AbbVie | 2017-05-09 |
| Compare Bioavailability of RO7239361 After Subcutaneous Injection (NCT03100630) | Hoffmann-La Roche | 2017-05-09 |
| A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease (NCT03117738) | Nature Cell Co. Ltd. | 2017-05-09 |
| Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma (NCT03074825) | Chipscreen Biosciences, Ltd. | 2017-05-09 |
| Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals (NCT03181841) | University of Zurich | 2017-05-08 |
| A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC (NCT02981108) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2017-05-08 |
| Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT02993146) | National Cancer Institute (NCI) | 2017-05-08 |